Published in Clin Dermatol on January 30, 1997
SCH708980 With and Without AmBisome for Visceral Leishmaniasis | NCT01437020
Leishmaniasis worldwide and global estimates of its incidence. PLoS One (2012) 18.07
Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis (2008) 3.27
A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ (2006) 3.11
Risk factors for kala-azar in Bangladesh. Emerg Infect Dis (2005) 2.73
Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy. PLoS Negl Trop Dis (2009) 2.56
Estimation of under-reporting of visceral leishmaniasis cases in Bihar, India. Am J Trop Med Hyg (2010) 1.98
Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J Clin Invest (2000) 1.98
Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal. Am J Trop Med Hyg (2010) 1.74
Diagnostic accuracy of two rK39 antigen-based dipsticks and the formol gel test for rapid diagnosis of visceral leishmaniasis in northeastern Uganda. J Clin Microbiol (2005) 1.67
Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes. Antimicrob Agents Chemother (2004) 1.63
Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial. PLoS Negl Trop Dis (2010) 1.54
Serial quantitative PCR assay for detection, species discrimination, and quantification of Leishmania spp. in human samples. J Clin Microbiol (2011) 1.48
Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs. PLoS Negl Trop Dis (2011) 1.42
Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in bihar, India. Am J Trop Med Hyg (2010) 1.34
Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal. Antimicrob Agents Chemother (2005) 1.34
Domestic animals and epidemiology of visceral leishmaniasis, Nepal. Emerg Infect Dis (2010) 1.29
Impact of the El Niño/Southern Oscillation on visceral leishmaniasis, Brazil. Emerg Infect Dis (2002) 1.27
Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis. J Clin Microbiol (2006) 1.26
Diagnosis of cutaneous leishmaniasis in Colombia: the sampling site within lesions influences the sensitivity of parasitologic diagnosis. J Clin Microbiol (2000) 1.26
Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study. PLoS Negl Trop Dis (2010) 1.19
Predicting geographic variation in cutaneous leishmaniasis, Colombia. Emerg Infect Dis (2004) 1.18
A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar. Am J Hum Genet (2003) 1.14
Population preference of net texture prior to bed net trial in Kala-Azar-endemic areas. PLoS Negl Trop Dis (2007) 1.13
Prevention of canine leishmaniosis in a hyper-endemic area using a combination of 10% imidacloprid/4.5% flumethrin. PLoS One (2013) 1.11
A review of preventative methods against human leishmaniasis infection. PLoS Negl Trop Dis (2013) 1.09
Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol (2005) 1.09
Evaluation of rK-39 strip test using urine for diagnosis of visceral leishmaniasis in an endemic region of India. Am J Trop Med Hyg (2012) 1.09
Phlebotomine vector ecology in the domestic transmission of American cutaneous leishmaniasis in Chaparral, Colombia. Am J Trop Med Hyg (2011) 1.08
Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a murine model. Antimicrob Agents Chemother (1997) 1.07
Current epidemiological profile and features of visceral leishmaniasis in people's republic of China. Parasit Vectors (2012) 1.03
Recombinant leishmania antigens for serodiagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol (2005) 1.03
Molecular detection of Leishmania parasites from whole bodies of sandflies collected in Nepal. Parasitol Res (2008) 1.03
In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate. BMC Pharmacol (2002) 1.03
Visceral leishmaniasis prevalence and associated risk factors in the saran district of Bihar, India, from 2009 to July of 2011. Am J Trop Med Hyg (2013) 1.02
Immunotherapy and targeted therapies in treatment of visceral leishmaniasis: current status and future prospects. Front Immunol (2014) 1.00
Visceral leishmaniasis: new health tools are needed. PLoS Med (2005) 0.99
Identification of a disulfide isomerase protein of Leishmania major as a putative virulence factor. Infect Immun (2002) 0.98
Leishmaniases in Greece. Am J Trop Med Hyg (2013) 0.97
First comparative transcriptomic analysis of wild adult male and female Lutzomyia longipalpis, vector of visceral leishmaniasis. PLoS One (2013) 0.96
Selection of endogenous reference genes for gene expression analysis in Leishmania major developmental stages. Parasitol Res (2007) 0.96
Methods of Control of the Leishmania infantum Dog Reservoir: State of the Art. Vet Med Int (2011) 0.96
Protective immunity and vaccination against cutaneous leishmaniasis. Front Immunol (2012) 0.95
Insecticide resistance and its molecular basis in urban insect pests. Parasitol Res (2016) 0.90
Miltefosine (Impavido): the first oral treatment against leishmaniasis. Med Microbiol Immunol (2003) 0.90
Mycobacterium hsp65 DNA entrapped into TDM-loaded PLGA microspheres induces protection in mice against Leishmania (Leishmania) major infection. Parasitol Res (2006) 0.90
Manifestations of paediatric Leishmania infantum infections in Malta. Travel Med Infect Dis (2011) 0.90
The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs. Am J Trop Med Hyg (2013) 0.89
Improvement of in vitro and in vivo antileishmanial activities of 2', 6'-dihydroxy-4'-methoxychalcone by entrapment in poly(D,L-lactide) nanoparticles. Antimicrob Agents Chemother (1999) 0.88
Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh. Clin Diagn Lab Immunol (2005) 0.88
Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation. Antimicrob Agents Chemother (2006) 0.87
Topoisomerase I amino acid substitutions, Gly185Arg and Asp325Glu, confer camptothecin resistance in Leishmania donovani. Antimicrob Agents Chemother (2005) 0.87
Evaluation of serum levels of zinc, copper, iron, and zinc/copper ratio in cutaneous leishmaniasis. Iran J Arthropod Borne Dis (2009) 0.87
A controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensis. Am J Trop Med Hyg (2010) 0.86
Role of remote sensing, geographical information system (GIS) and bioinformatics in kala-azar epidemiology. J Biomed Res (2011) 0.86
Peganum harmala Aqueous and Ethanol Extracts Effects on Lesions Caused by Leishmania major (MRHO/IR/75/ER) in BALB/c Mice. Jundishapur J Microbiol (2014) 0.86
Natural infection of the sand fly Phlebotomus kazeruni by Trypanosoma species in Pakistan. Parasit Vectors (2010) 0.85
An evaluation of the performance of direct agglutination test on filter paper blood sample for the diagnosis of visceral leishmaniasis. Am J Trop Med Hyg (2014) 0.85
Epidemiologic profile of oriental sore caused by Leishmania parasites in a new endemic focus of cutaneous leishmaniasis, southern Iran. J Parasit Dis (2014) 0.85
Vector and reservoir control for preventing leishmaniasis. Cochrane Database Syst Rev (2015) 0.85
Knowledge, attitude and practices related to visceral leishmaniasis among residents in Addis Zemen town, South Gondar, Northwest Ethiopia. BMC Public Health (2013) 0.85
Single-dose liposomal amphotericin B (AmBisome®) for the treatment of visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial. Trials (2011) 0.84
Vector saliva in vaccines for visceral leishmaniasis: a brief encounter of high consequence? Front Public Health (2014) 0.84
Species composition and seasonal abundance of sandflies (Diptera: Psychodidae: Phlebotominae) in coffee agroecosystems. Mem Inst Oswaldo Cruz (2013) 0.84
Crystal structure of arginase from Leishmania mexicana and implications for the inhibition of polyamine biosynthesis in parasitic infections. Arch Biochem Biophys (2013) 0.83
Endemic characteristics of infantile visceral leishmaniasis in the People's Republic of China. Parasit Vectors (2013) 0.83
Leishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B-cell differentiation and in vivo production of specific antibodies. Immunology (2006) 0.83
The Comparative Genomics and Phylogenomics of Leishmania amazonensis Parasite. Evol Bioinform Online (2014) 0.83
Inbred strains derived from feral mice reveal new pathogenic mechanisms of experimental leishmaniasis due to Leishmania major. Infect Immun (2004) 0.82
Prevalence of sand flies and Leishmania donovani infection in a natural population of female Phlebotomus argentipes in Bihar State, India. Vector Borne Zoonotic Dis (2012) 0.82
Stage-specific differential gene expression in Leishmania infantum: from the foregut of Phlebotomus perniciosus to the human phagocyte. BMC Genomics (2014) 0.81
In situ hybridisation for the detection of Leishmania species in paraffin wax-embedded canine tissues using a digoxigenin-labelled oligonucleotide probe. Vet Rec (2011) 0.81
Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines. J Med Chem (2014) 0.81
Performance of rK39 immunochromatography and freeze-dried direct agglutination tests in the diagnosis of imported visceral leishmaniasis. Parasitol Res (2011) 0.80
The crystal structure of the Leishmania major deoxyuridine triphosphate nucleotidohydrolase in complex with nucleotide analogues, dUMP, and deoxyuridine. J Biol Chem (2011) 0.80
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial. PLoS Negl Trop Dis (2016) 0.79
46-year-old man with fevers, chills, and pancytopenia. Mayo Clin Proc (2012) 0.79
The characterization of the Phlebotomus papatasi transcriptome. Insect Mol Biol (2013) 0.79
Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity. PLoS Negl Trop Dis (2015) 0.79
Gene expression analysis of wild Leishmania major isolates: identification of genes preferentially expressed in amastigotes. Parasitol Res (2006) 0.79
Trypanosomatid comparative genomics: Contributions to the study of parasite biology and different parasitic diseases. Genet Mol Biol (2012) 0.79
Association of Ficolin-2 Serum Levels and FCN2 Genetic Variants with Indian Visceral Leishmaniasis. PLoS One (2015) 0.79
Leishmaniases diagnosis: an update on the use of immunological and molecular tools. Cell Biosci (2015) 0.79
Evidence for involvement of TNFR1 and TIMPs in pathogenesis of post-kala-azar dermal leishmaniasis. Clin Exp Immunol (2008) 0.78
Changes in T-Cell and Monocyte Phenotypes In Vitro by Schistosoma mansoni Antigens in Cutaneous Leishmaniasis Patients. J Parasitol Res (2012) 0.78
Influence of the Microenvironment in the Transcriptome of Leishmania infantum Promastigotes: Sand Fly versus Culture. PLoS Negl Trop Dis (2016) 0.78
Comorbidity of leishmania major with cutaneous sarcoidosis. Indian J Dermatol (2014) 0.78
PCR-RFLP based method for molecular differentiation of sand fly species Phlebotomus argentipes, Phlebotomus papatasi, and Sergentomyia babu found in India. J Med Entomol (2012) 0.78
Some epidemiological aspects of cutaneous leishmaniasis in northern khorasan province, iran. Iran J Arthropod Borne Dis (2009) 0.78
Detection of anti-leishmania (Leishmania) chagasi immunoglobulin G by flow cytometry for cure assessment following chemotherapeutic treatment of American visceral leishmaniasis. Clin Vaccine Immunol (2007) 0.78
Epidemiologic Correlates of Mortality among Symptomatic Visceral Leishmaniasis Cases: Findings from Situation Assessment in High Endemic Foci in India. PLoS Negl Trop Dis (2016) 0.78
Furazolidone is a selective in vitro candidate against Leishmania (L.) chagasi: an ultrastructural study. Parasitol Res (2010) 0.77
Concomitant Infection with Leishmania donovani and L. major in Single Ulcers of Cutaneous Leishmaniasis Patients from Sudan. J Trop Med (2014) 0.77
In vitro infectivity and differential gene expression of Leishmania infantum metacyclic promastigotes: negative selection with peanut agglutinin in culture versus isolation from the stomodeal valve of Phlebotomus perniciosus. BMC Genomics (2016) 0.77
Repeated training of accredited social health activists (ASHAs) for improved detection of visceral leishmaniasis cases in Bihar, India. Pathog Glob Health (2016) 0.77
Identification and Characterization of a Novel, 37-Kilodalton Leishmania donovani antigen for diagnosis of Indian visceral leishmaniasis. Clin Vaccine Immunol (2011) 0.76
Kinetoplastid Membrane Protein-11 as a Vaccine Candidate and a Virulence Factor in Leishmania. Front Immunol (2015) 0.76
Computational analysis of cysteine proteases (Clan CA, Family Cl) of Leishmania major to find potential epitopic regions. Genomics Proteomics Bioinformatics (2009) 0.76
Leishmanicidal Activity of Films Containing Paromomycin and Gentamicin Sulfate both In Vitro and In Vivo. Iran J Parasitol (2011) 0.75